Vesicor Therapeutics, Inc.

SAN GABRIEL, CA · CIK 0001993074 · Biotech · Private

Non-viral, immune-silent gene therapy delivery platform for cancer

vesicor.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$715K
2 Form D · May 2025
17 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$200,000
Private capital raisedForm D · SEC$515,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1969F-STOP, LLC—$85K
1970CMP TARNHELM PARTNERS, LLC——
1971VAST THERAPEUTICS, INC.——
1972Vesicor Therapeutics, Inc.—$715K
1973FasCure Therapeutics LLC——
1974UBIQUITX, INC.——
1975ACCUNOVO BIOTECHNOLOGIES INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Michael BowenExecutive Officer
  • Luo FengDirector · Executive Officer
  • Warren HosseinionDirector
  • Warren Jr. HosseinionExecutive Officer
  • Warren HosseinionnDirector
  • Oded LevyDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.